Pfizer (NYSE: PFE) is a great example, with its shares down around 57% below the previous high. When a stock plunges as much ...

Investing in stocks inevitably means buying into some companies that perform poorly. But the long term shareholders ...

Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed. So should PMV Pharmaceuticals (NASDAQ:PMVP) shareholders be worried ...

Industries reliant on vast energy resources have fallen by a third in the U.K. since 2021, marking their lowest level since ...

DUBLIN, May 21, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the following investor conferences: Jefferies Global Healthcare ...

SARASOTA, FL, May 21, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delive ...

The surgeon-turned-author is a vaccine skeptic that has embraced the Health and Human Services Secretary’s ‘Make America ...

The tariff war the U.S. is waging against most of the world stabilized somewhat earlier this month. But let's face facts -- ...

A pharmaceutical company sued several prominent telehealth companies for what they call "illegal knock offs" of their drugs.

For J&J, there was a positive outcome as the Oncologic Drugs Advisory Committee (ODAC) voted six to two in favour of approval ...

2 M&A plays a key role in bringing highly lucrative medications to market, as large pharmaceutical companies often look to invest in young biotechnology companies for their innovative products.

Genetic testing firm 23andMe is set to be acquired by drug company Regeneron Pharmaceuticals following its bankruptcy in March, the companies announced on Monday, May 19. Regeneron purchased the ...